Bucindolol

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Bucindolol
Bucindolol.png
Systematic (IUPAC) name
2-[2-hydroxy-3-[[2-(1H-indol-3-yl)-1,1-dimethyl-ethyl]amino]propoxy]benzonitrile
Identifiers
CAS Number 71119-11-4
ATC code none
PubChem CID: 51045
ChemSpider 46266
UNII E9UO06K7CE YesY
ChEMBL CHEMBL2107546
Chemical data
Formula C22H25N3O2
Molecular mass 363.45 g/mol

Bucindolol is a non-selective beta blocker with additional weak alpha-blocking properties and some intrinsic sympathomimetic activity.[1][2] It was under review by the FDA in the United States for the treatment of heart failure in 2009, but was rejected due to issues pertaining to integrity of data submitted.[1][3]

See also

References

  1. ↑ 1.0 1.1 Lua error in package.lua at line 80: module 'strict' not found.
  2. ↑ Lua error in package.lua at line 80: module 'strict' not found.
  3. ↑ Lua error in package.lua at line 80: module 'strict' not found.



<templatestyles src="Asbox/styles.css"></templatestyles>

40px

This antihypertensive-related article is a stub. You can help Wikipedia by expanding it.
Retrieved from "https://infogalactic.com/w/index.php?title=Bucindolol&oldid=4647194"